Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam I Kaplin

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Journal of Clinical Investigation|September 27, 2005
IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitisAdam I Kaplin, Deepa M Deshpande, Erick Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosisKristen A Rahn, Crystal C Watkins, Jesse Alt, et al.
Archives of Neurology|June 11, 2008
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosisChitra Krishnan, Adam I Kaplin, Robert A Brodsky, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Journal of Clinical Investigation|September 27, 2005
IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitisAdam I Kaplin, Deepa M Deshpande, Erick Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosisKristen A Rahn, Crystal C Watkins, Jesse Alt, et al.
Archives of Neurology|June 11, 2008
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosisChitra Krishnan, Adam I Kaplin, Robert A Brodsky, et al.
Pageof 3